IGFBP1 and diabetes mellitus: Increased insulin exposure due to insulin resistance or even insulin administration in patients with diabetes may contribute to carcinogenesis [8] through the upregulation of IGF-I activity or downregulation of IGF-binding protein-1 activity [39].